Location
Turner Gymnasium
Access Type
Campus Access Only
Presentation Type
Printed poster
Entry Number
2314
Start Date
4-16-2025 12:00 PM
End Date
4-16-2025 1:15 PM
School
School of Medicine and Health Sciences
Department
Nursing
Keywords
Bee venom, Lyme Disease, Melittin, Tick borne illness
Abstract
Lyme Disease is a tick borne illness, caused from a bacterial infection as a result of being bitten by a tick. Traditionally, lyme disease is treated with antibiotics, such as doxycycline and amoxicillin. However, there are so many patients who have long lasting symptoms from lyme disease whether they were treated with antibiotics or not. There is new research that suggests the use of bee venom for therapeutic use can be an effective form of antimicrobial treatment for B. burgdorferi, which is the pathogen responsible for lyme disease. By examining existing research from 2019 to 2024, this review synthesizes findings from various quantitative and qualitative studies, through systematic reviews and meta-analysis. The findings show that bee venom therapy, as opposed to traditional antibiotic therapy, contains Melittin, a strong anti-inflammatory that induces cortisol, Apamin, a mild neurotoxin that increases the production of cortisol within the adrenal gland, and Adolapin, which acts as an additional form of anti-inflammatory and an analgesic. As a result, bee venom therapy uses these pharmacological components to intensify the management of symptoms that come from long-lasting lyme disease pain. Through research the goal is to recommend that the use of bee venom can be an effective form of treatment for lymes disease symptom management, instead of the antibiotics that are typically ordered.
Primary Faculty Mentor(s)
Dr. Susan Braud
Primary Faculty Mentor(s) Department
Dr. Kopis, Department of Nursing
Rights Statement
The right to download or print any portion of this material is granted by the copyright owner only for personal or educational use. The author/creator retains all proprietary rights, including copyright ownership. Any editing, other reproduction or other use of this material by any means requires the express written permission of the copyright owner. Except as provided above, or for any other use that is allowed by fair use (Title 17, §107 U.S.C.), you may not reproduce, republish, post, transmit or distribute any material from this web site in any physical or digital form without the permission of the copyright owner of the material.
Final Abstract
Bee Venom Therapy for the Treatment of Lyme Disease
Turner Gymnasium
Lyme Disease is a tick borne illness, caused from a bacterial infection as a result of being bitten by a tick. Traditionally, lyme disease is treated with antibiotics, such as doxycycline and amoxicillin. However, there are so many patients who have long lasting symptoms from lyme disease whether they were treated with antibiotics or not. There is new research that suggests the use of bee venom for therapeutic use can be an effective form of antimicrobial treatment for B. burgdorferi, which is the pathogen responsible for lyme disease. By examining existing research from 2019 to 2024, this review synthesizes findings from various quantitative and qualitative studies, through systematic reviews and meta-analysis. The findings show that bee venom therapy, as opposed to traditional antibiotic therapy, contains Melittin, a strong anti-inflammatory that induces cortisol, Apamin, a mild neurotoxin that increases the production of cortisol within the adrenal gland, and Adolapin, which acts as an additional form of anti-inflammatory and an analgesic. As a result, bee venom therapy uses these pharmacological components to intensify the management of symptoms that come from long-lasting lyme disease pain. Through research the goal is to recommend that the use of bee venom can be an effective form of treatment for lymes disease symptom management, instead of the antibiotics that are typically ordered.